Rhythm Biosciences sees best day in 3 yrs as cancer test device gets UK nod

Rhythm Biosciences

17/05/2023 03:54

** Shares of Australia's Rhythm Biosciences Ltd  RHY.AX 
jump as much as 137.1% to A$0.830 - set for best day since April
2020, if gains hold
    ** Medical diagnostics co says its cancer detection
technology product, ColoSTAT, granted UK CA (United Kingdom
Conformity Assessment) mark
    ** Co says attestation enables it to market and sell
ColoSTAT in the UK 
    ** Stock at its highest level since Feb 28
    ** Stock down ~65% YTD, as of last close
 

 (Reporting by Ayushman Ojha in Bengaluru)
 ((Ayushman.ojha@thomsonreuters.com;))